Overview

Evaluation of Atuna Racemosa Toxicity

Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
For thousands of years people in the South Pacific have used Atuna racemosa extract as a topical anti-inflammatory. We, the researchers at the Mayo Clinic, have shown this extract to also have antibacterial properties. While this extract has been used for decades in the South Pacific, a controlled clinical trial to evaluate toxicity has never been performed.
Phase:
Phase 1
Details
Lead Sponsor:
Mayo Clinic